تأثیر پرتوگیری مزمن بر ساکنین مناطق با پرتوزایی طبیعی بالا در شهر رامسر، استفاده از روش سیتوژنتیک سنجش هستک­های متوقف شده مرحله سیتوکینز و مقایسه­ی نتایج میان دو گروه مورد مطالعه کنترل، بررسی قرار گرفت. نشان داد اختلاف معنی­داری (001/0< P) میانگین فرکانس شمارش لنفوسیت­های خون محیطی (ساکن منطقه­ی بالای رامسر) کنترل تنکابن) وجود دارد. هم­چنین، بعد پرتودهی نمونه­ها، افزایش بیش­تری را هستک­ها نسبت ...

In the mid 1990s, immunoassays for C-reactive protein (CRP), with greater sensitivity than those previously in routine use, revealed that increased CRP values, even within the range previously considered normal, strongly predict future coronary events. These findings triggered widespread interest, especially, remarkably, in the US, where the clinical use of CRP measurement had been largely igno...

INTRODUCTION Residual inflammation at ICU discharge may have impact upon long-term mortality. However, the significance of ongoing inflammation on mortality after ICU discharge is poorly described. C-reactive protein (CRP) and albumin are measured frequently in the ICU and exhibit opposing patterns during inflammation. Since infection is a potent trigger of inflammation, we hypothesized that CR...

C-reactive protein (CRP) is a cyclic pentameric protein whose major binding specificity, at physiological pH, is for substances bearing exposed phosphocholine moieties. Another pentameric form of CRP, which exists at acidic pH, displays binding activity for oxidized LDL (ox-LDL). The ox-LDL-binding site in CRP, which is hidden at physiological pH, is exposed by acidic pH-induced structural chan...

Human C-reactive protein (CRP) protects mice from lethality after infection with virulent Streptococcus pneumoniae type 3. For CRP-mediated protection, the complement system is required; however, the role of complement activation by CRP in the protection is not defined. Based on the in vitro properties of CRP, it has been assumed that protection of mice begins with the binding of CRP to pneumoc...

Methods This was a secondary analysis of a prospective cohort of cancer patients admitted to three ICUs with the diagnosis of HCAP. CRP was sampled every other day from D0 do D6 of antibiotic prescription. Patients were classified according to an individual pattern of CRP-ratio response with the following criteria: fast response when CRP at day 4 of therapy was < 0.4 of day 0 CRP; slow response...